Although we did not observe any toxicity in the mouse model, long-term application in patients needs to be carefully surveilled and clinical trials are needed to investigate this interesting combination to improve the results of targeted therapy of BRAF mutated malignant melanoma. This evidence concerns the gene BRAF and melanoma.